Suppr超能文献

在经历V(D)J重组的细胞中,Miz-1通过核糖体蛋白L22调节Trp53的翻译。

Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination.

作者信息

Rashkovan Marissa, Vadnais Charles, Ross Julie, Gigoux Mathieu, Suh Woong-Kyung, Gu Wei, Kosan Christian, Möröy Tarik

机构信息

Institut de recherches cliniques de Montréal, Montréal, QC, Canada H2W 1R7; Division of Experimental Medicine, McGill University, Montréal, QC, Canada H3A 1A3;

Institut de recherches cliniques de Montréal, Montréal, QC, Canada H2W 1R7;

出版信息

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5411-9. doi: 10.1073/pnas.1412107111. Epub 2014 Dec 2.

Abstract

To be effective, the adaptive immune response requires a large repertoire of antigen receptors, which are generated through V(D)J recombination in lymphoid precursors. These precursors must be protected from DNA damage-induced cell death, however, because V(D)J recombination generates double-strand breaks and may activate p53. Here we show that the BTB/POZ domain protein Miz-1 restricts p53-dependent induction of apoptosis in both pro-B and DN3a pre-T cells that actively rearrange antigen receptor genes. Miz-1 exerts this function by directly activating the gene for ribosomal protein L22 (Rpl22), which binds to p53 mRNA and negatively regulates its translation. This mechanism limits p53 expression levels and thus contains its apoptosis-inducing functions in lymphocytes, precisely at differentiation stages in which V(D)J recombination occurs.

摘要

为了发挥作用,适应性免疫反应需要大量的抗原受体库,这些受体是通过淋巴前体细胞中的V(D)J重组产生的。然而,这些前体细胞必须受到保护,以免因DNA损伤诱导细胞死亡,因为V(D)J重组会产生双链断裂并可能激活p53。我们在此表明,BTB/POZ结构域蛋白Miz-1在积极重排抗原受体基因的前B细胞和DN3a前T细胞中,限制p53依赖的凋亡诱导。Miz-1通过直接激活核糖体蛋白L22(Rpl22)的基因发挥此功能,Rpl22与p53 mRNA结合并负调节其翻译。这种机制限制了p53的表达水平,从而在淋巴细胞中抑制其凋亡诱导功能,特别是在发生V(D)J重组的分化阶段。

相似文献

1
Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination.
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5411-9. doi: 10.1073/pnas.1412107111. Epub 2014 Dec 2.
2
Miz-1 is required to coordinate the expression of TCRbeta and p53 effector genes at the pre-TCR "beta-selection" checkpoint.
J Immunol. 2011 Sep 15;187(6):2982-92. doi: 10.4049/jimmunol.1101451. Epub 2011 Aug 12.
3
4
Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint.
J Immunol. 2015 Jan 1;194(1):200-9. doi: 10.4049/jimmunol.1402242.
5
Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Cancer Res. 2007 Dec 1;67(23):11317-26. doi: 10.1158/0008-5472.CAN-07-1088.
7
Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis.
Nat Genet. 1997 Dec;17(4):479-82. doi: 10.1038/ng1297-479.
8
ARF antagonizes the ability of Miz-1 to inhibit p53-mediated transactivation.
Oncogene. 2010 Feb 4;29(5):711-22. doi: 10.1038/onc.2009.372. Epub 2009 Nov 9.
9
Deletion of the Miz-1 POZ Domain Increases Efficacy of Cytarabine Treatment in T- and B-ALL/Lymphoma Mouse Models.
Cancer Res. 2019 Aug 15;79(16):4184-4195. doi: 10.1158/0008-5472.CAN-18-3038. Epub 2019 Jul 4.

引用本文的文献

1
The Central Role of Ribosomal Proteins in p53 Regulation.
Cancers (Basel). 2025 May 8;17(10):1597. doi: 10.3390/cancers17101597.
2
Conserved role of hnRNPL in alternative splicing of epigenetic modifiers enables B cell activation.
EMBO Rep. 2024 Jun;25(6):2662-2697. doi: 10.1038/s44319-024-00152-3. Epub 2024 May 14.
3
Regulation of BCR-mediated Ca mobilization by MIZ1-TMBIM4 safeguards IgG1 GC B cell-positive selection.
Sci Immunol. 2024 Apr 5;9(94):eadk0092. doi: 10.1126/sciimmunol.adk0092.
4
Genetic distinction between functional tissue-resident and conventional natural killer cells.
iScience. 2023 Jun 20;26(7):107187. doi: 10.1016/j.isci.2023.107187. eCollection 2023 Jul 21.
6
ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells.
Front Immunol. 2021 Jul 19;12:713294. doi: 10.3389/fimmu.2021.713294. eCollection 2021.
7
Stressed: The Unfolded Protein Response in T Cell Development, Activation, and Function.
Int J Mol Sci. 2019 Apr 11;20(7):1792. doi: 10.3390/ijms20071792.
8
Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex.
Cell Cycle. 2019 Mar-Apr;18(6-7):759-770. doi: 10.1080/15384101.2019.1593708. Epub 2019 Mar 28.
9
Regulation of the Development and Function of B Cells by ZBTB Transcription Factors.
Front Immunol. 2018 Mar 20;9:580. doi: 10.3389/fimmu.2018.00580. eCollection 2018.
10
Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.
Oncotarget. 2017 Oct 6;8(53):90651-90661. doi: 10.18632/oncotarget.21544. eCollection 2017 Oct 31.

本文引用的文献

1
Miz1 is required to maintain autophagic flux.
Nat Commun. 2013;4:2535. doi: 10.1038/ncomms3535.
2
The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1.
PLoS Genet. 2013;9(8):e1003708. doi: 10.1371/journal.pgen.1003708. Epub 2013 Aug 22.
3
Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.
Cell. 2012 Jun 8;149(6):1269-83. doi: 10.1016/j.cell.2012.04.026.
4
Fast gapped-read alignment with Bowtie 2.
Nat Methods. 2012 Mar 4;9(4):357-9. doi: 10.1038/nmeth.1923.
5
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.
Immunity. 2011 Dec 23;35(6):871-82. doi: 10.1016/j.immuni.2011.09.021.
6
Miz-1 is required to coordinate the expression of TCRbeta and p53 effector genes at the pre-TCR "beta-selection" checkpoint.
J Immunol. 2011 Sep 15;187(6):2982-92. doi: 10.4049/jimmunol.1101451. Epub 2011 Aug 12.
7
Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors.
J Immunol. 2011 Jul 15;187(2):664-75. doi: 10.4049/jimmunol.1100029. Epub 2011 Jun 20.
10
5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage.
Genes Dev. 2010 Oct 1;24(19):2146-56. doi: 10.1101/gad.1968910. Epub 2010 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验